FDA greenlights bivalent vaccines for children as young as 6 months old
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The FDA’s rodent problem worsened during the pandemic, forcing the agency to assign some employees returning to the campus after two years to temporary desks and ask others to continue to telework.
The FDA’s rodent problem worsened during the pandemic, forcing the agency to assign some employees returning to the campus after two years to temporary desks and ask others to continue to telework.
The FDA’s rodent problem worsened during the pandemic, forcing the agency to assign some employees returning to the campus after two years to temporary desks and ask others to continue to telework.
The FDA’s rodent problem worsened during the pandemic, forcing the agency to assign some employees returning to the campus after two years to temporary desks and ask others to continue to telework.
The FDA’s rodent problem worsened during the pandemic, forcing the agency to assign some employees returning to the campus after two years to temporary desks and ask others to continue to telework.
The FDA’s rodent problem worsened during the pandemic, forcing the agency to assign some employees returning to the campus after two years to temporary desks and ask others to continue to telework.
FDA is set to convene its advisory committee of vaccine experts next month to deliberate how to approach Covid booster shots.
FDA is set to convene its advisory committee of vaccine experts next month to deliberate how to approach Covid booster shots.
FDA is set to convene its advisory committee of vaccine experts next month to deliberate how to approach Covid booster shots.
FDA is set to convene its advisory committee of vaccine experts next month to deliberate how to approach Covid booster shots.
“The recent emergence of the Omicron variant further emphasizes the importance of vaccination, boosters and prevention efforts needed to protect against Covid-19,” CDC Director Rochelle Walensky said.
“The recent emergence of the Omicron variant further emphasizes the importance of vaccination, boosters and prevention efforts needed to protect against Covid-19,” CDC Director Rochelle Walensky said.